Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE , more than five years after both ...

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.

Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations.

A stunning new study offers early evidence that COVID-19 vaccines might have a secret superpower: a precisely timed mRNA shot could help many cancer patients live longer.

Pfizer (PFE) exceeded Street forecasts with its Q3 2025 results on Tuesday, thanks mainly to sales from its COVID vaccine ...

Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.

Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.

COVID-19 mRNA vaccines may enhance the effects of immunotherapy drugs in cancer patients, potentially improving survival rates.

Delaware says COVID-19 vaccines are available at state clinics, regardless of insurance status. But only 2 clinics carried ...

COVID-19 vaccines for children between the ages of 5 and 11 could get the green light from the US Food and Drug Administration sometime this fall, Dr. Anthony Fauci said. "If you look at the studies ...